Literature DB >> 1388632

Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compounds.

M Maliepaard1, N J de Mol, L H Janssen, W van der Neut, W Verboom, D N Reinhoudt.   

Abstract

The antitumour activity of a series of mitosene compounds in various in vitro tumour models was evaluated in terms of physico-chemical parameters. Lipophilicity, measured as log P, seemed to be important for in vitro antitumour activity in three different cell lines. The in vitro activity of this series of mitosenes in an A204 and a L1210 cell line demonstrated a clear bilinear dependence on log P with optimal activity at log P values of 2.8 and 3.3 respectively. Compounds not able to be activated to bifunctional alkylating species did not fit into this correlation. Although mitosenes have to be activated reductively to alkylating species, no correlation was found between the half-wave reduction potential (E 1/2) and the in vitro activity. This lack of correlation may be caused by the relatively small range of E 1/2-values within this series of mitosene compounds. Our results indicate that penetration of the antitumour mitosenes into the cell and the site of activation is an important process that leads to antitumour activity and that within the range of compounds studied the structural variations are less important for bioreductive activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388632

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  4 in total

Review 1.  Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approaches.

Authors:  Phillip D Bass; Daniel A Gubler; Ted C Judd; Robert M Williams
Journal:  Chem Rev       Date:  2013-05-08       Impact factor: 60.622

2.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

3.  Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.

Authors:  Agata M Wasik; Michael N Gandy; Matthew McIldowie; Michelle J Holder; Anita Chamba; Anita Challa; Katie D Lewis; Stephen P Young; Dagmar Scheel-Toellner; Martin J Dyer; Nicholas M Barnes; Matthew J Piggott; John Gordon
Journal:  Invest New Drugs       Date:  2011-08-18       Impact factor: 3.850

4.  p53-independent structure-activity relationships of 3-ring mesogenic compounds' activity as cytotoxic effects against human non-small cell lung cancer lines.

Authors:  Saori Fukushi; Hironori Yoshino; Atsushi Yoshizawa; Ikuo Kashiwakura
Journal:  BMC Cancer       Date:  2016-07-25       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.